The present embodiments relate generally to medical devices, and more particularly, to stent designs having enhanced radiopacity.
Stents may be inserted into an anatomical vessel or duct to maintain or restore patency in a constricted passageway, or may be used for other purposes. Stents may be manufactured using materials such as plastic or metal, and may comprise a variety of configurations, for example, a wire-mesh, coil or helical shape, or a slotted tube configuration.
Stents may be self-expanding or balloon expandable, or combinations thereof. A self-expanding stent may be delivered to a target site in a compressed configuration and subsequently expanded by removing a delivery sheath. In such embodiments, the stent may comprise a shape-memory alloy such as nitinol that allows the stent to return to a predetermined configuration upon removal of the sheath. By contrast, a balloon expandable stent may be delivered using a balloon catheter. In such a procedure, the catheter may be inserted over a wire guide into a vessel or duct and advanced until the stent is aligned at the target site, and the stent then may be deployed by inflating the balloon to expand the stent diameter, whereby the stent engages and may slightly expand the lumen diameter of the vessel or duct.
When deploying a stent according to either self-expanding or balloon expandable techniques, it is important for a physician to clearly view the stent, or at least portions of the stent, using a suitable imaging modality, such as fluoroscopy. In particular, it may be desirable to view selected regions of a stent, such as the proximal end, the distal end, regions to be aligned with a stricture, and/or other pertinent areas during placement of the stent. For example, when implanting a stent across a stricture, it may be desirable or necessary to identify the boundaries of the stent portion to be disposed across the stricture versus other portions of the stent that are intended to be disposed proximal and distal to the stricture.
Various existing stents employ radiopaque markers, which may comprise a material such as tantalum, platinum, gold, or another imageable material, that is coupled to the stent in a region of interest. However, such radiopaque markers are generally limited in size based on the strut portion to which they are attached, and can therefore appear relatively small when viewed under fluoroscopy or other techniques.
Still other stents attempt to increase visibility during implantation by providing thicker wire cross-sections. However, increasing the wire thickness may reduce flexibility of the individual struts forming the stent, and may cause wires to straighten the lumen of the duct or vessel into which they are implanted, which can lead to patient discomfort and possible perforation of a passageway. Further, if such a stent is placed in a passageway such as the lower esophageal sphincter, the stent may exacerbate gastroesophageal reflux by not allowing the lower esophageal sphincter to close properly. In sum, providing thicker wire cross-sections and/or radiopaque markers are not always desirable solutions for enhanced visualization of selected regions of a stent.
The present embodiments provide stents for use in medical procedures. In one embodiment, a stent comprises a first flanged region and a body region. A first diameter of the first flanged region is greater than a second diameter of the body region when the stent is in an expanded deployed state. A proximal junction is formed between the first flanged region and the body region. The proximal junction comprises at least one strut extending from the distal end of the first flanged region in a distal direction towards the proximal end of the body region. A strut at the proximal end of the body region is disposed around at least a portion of the strut of the proximal junction. The overlap between the strut at the proximal end of the body region with the strut of the proximal junction causes an increased radiopaque effect at the proximal junction.
In one embodiment, the strut of the proximal junction comprises first and second segments that extend distally from the first flanged region and converge at an apex. The strut at the proximal end of the body region may be disposed around the apex. Optionally, at least one separate loop member may encircle a zone in which the strut at the proximal end of the body region is disposed around the apex.
In one embodiment, the first and second segments of the strut of the proximal junction may form an integral loop member at the apex, and the strut at the proximal end of the body region is disposed through the integral loop member. In an alternative embodiment, an integral loop member is not formed, but rather an external loop member is coupled to the strut of the proximal junction at the apex. In the latter embodiment, the strut at the proximal end of the body region is disposed through the external loop member.
In a further alternative embodiment, the strut of the proximal junction comprises first and second segments that extend distally from the first flanged region and converge at an apex, wherein the apex is folded over in a proximal direction to form a generally W-shape in the strut of the proximal junction. The strut at the proximal end of the body region is disposed around the W-shape formed in the strut of the proximal junction. For example, the strut at the proximal end of the body region may be disposed in front of the W-shape at least two times, and may be disposed behind the W-shape at least two times.
Advantageously, in all of the embodiments, the proximal junction comprises a shape that enhances radiopacity when viewed using a suitable imaging modality, without the need to provide wider strut cross-sections or separate radiopaque markers. The enhanced radiopacity may allow a physician to readily identify the proximal junction during placement of the stent, which may be beneficial particularly when placing only the main body region within a target area such as a stricture.
Other systems, methods, features and advantages of the invention will be, or will become, apparent to one with skill in the art upon examination of the following figures and detailed description. It is intended that all such additional systems, methods, features and advantages be within the scope of the invention, and be encompassed by the following claims.
The invention can be better understood with reference to the following drawings and description. The components in the figures are not necessarily to scale, emphasis instead being placed upon illustrating the principles of the invention. Moreover, in the figures, like referenced numerals designate corresponding parts throughout the different views.
In the present application, the term “proximal” refers to direction that is generally towards a physician during a medical procedure, while the term “distal” refers to a direction that is generally towards a target site within a patent's anatomy during a medical procedure.
Referring now to
In the embodiment of
The stent 20 has a delivery state that is suitable for insertion into a target duct or vessel of a patient, and an expanded deployed state as shown in
The stent 20 further comprises a proximal junction 60 and a distal junction 70. The proximal junction 60 couples the distal end 44 of the first flanged region 40 to the proximal end 32 of the body region 30, as shown in
In the expanded deployed state of
In accordance with one aspect, the proximal and distal junctions 60 and 70 each comprise shapes that enhance radiopacity when viewed using a suitable imaging modality, as explained in further detail below. The enhanced radiopacity advantageously may allow a physician to readily identify the proximal and distal junctions 60 and 70 during placement of the stent 20, which may be beneficial particularly when placing only the body region 30 within a region such as a stricture.
In the embodiment of
In one embodiment, the struts 62a of the proximal junction 60 may be formed integrally with struts 45 at the distal end 44 of the first flanged region 40. In an alternative embodiment, the struts 62a may be formed as separate strut members that are coupled to the struts 45 using solder, a weld, an adhesive, a mechanical connection, and the like. It is not necessary that each strut 45 is coupled to a strut 62a. For example, one particular strut 45f of the first flanged region 40 lacks a direct coupling to the body region 30 via a strut 62a, as shown in
The second flanged region 50 may be coupled to the body region 30 via the distal junction 70 in a similar manner. In particular, the distal junction 70 comprises a series of struts 72a having first and second segments 73a and 74a, and a loop 76 through which corresponding struts 35 formed at the distal end 34 of the body region 30 are disposed. The characteristics of the struts 72a of the distal junction 70 may be identical to the struts 62a of the proximal junction 60, as explained in
Referring to
Advantageously, the enhanced radiopacity may allow a physician to readily identify the proximal and distal junctions 60 and 70 during placement of the stent 20, which may be beneficial particularly when placing only the body region 30 within a target area such as a stricture. Moreover, the proximal and distal junctions 60 and 70 comprise shapes that enhance radiopacity when viewed using a suitable imaging modality, such as fluoroscopy, without the need to provide separate radiopaque markers that may be limited in size due to the diameter of the wire to which they are attached. Further, the proximal and distal junctions 60 and 70 comprise shapes that enhance radiopacity without the need to provide wider strut cross-sections that can add to a bulky delivery profile and have a tendency to straighten when implanted in a curved vessel or duct.
For example, in the embodiment of
Referring now to
Referring to
Referring to
Referring to
In any of the embodiments above, the coupling features shown in
Further, in any of the embodiments above, various types of stents may be used along the body region 30, as well as the first and second flanged regions 40 and 50. In the example of
Alternatively, the body region 30, the first flanged region 40 and/or the second flanged region 50 may comprise shapes other than braided patterns. For example, one or more of these regions may comprise diamond-shaped struts, zig-zag shaped struts, or other shapes that may vary depending on the needs of the procedure.
Moreover, the stent 20 may be designed to be either balloon-expandable or self-expandable. The body region 30, the first flanged region 40 and the second flanged region 50 may be made from numerous metals and alloys, including stainless steel, nitinol, cobalt-chrome alloys, amorphous metals, tantalum, platinum, gold and titanium. The stent may also be made from non-metallic materials, such as thermoplastics and other polymers. The structure of stent 20 may also be formed in a variety of ways to provide a suitable intraluminal support structure, and may be made from a woven wire structure, a laser-cut cannula, individual interconnected rings, or any other type of stent structure that is known in the art. Optionally, one or more regions of the stent 20 may comprise a coating designed to achieve a desired biological effect.
Further, it will be apparent that while the stent 20 has been described primarily with respect to treatment of a stricture within a duct or vessel, the present embodiments may be used in other applications. For example, the apparatus and methods may be used in the treatment of aneurysms, whereby the stent 20 is coupled to a graft material along its length to provide a conduit for flow across the aneurysm, wherein the identifiable markers 69 and 79 of the proximal and distal junctions 60 and 70, respectively, identify proper placement of the stent 20 such that the first and second flanged regions 40 and 50 engage healthy tissue on opposing sides of the aneurysm.
While various embodiments of the invention have been described, it will be apparent to those of ordinary skill in the art that many more embodiments and implementations are possible within the scope of the invention. Accordingly, the invention is not to be restricted except in light of the attached claims and their equivalents. Moreover, the advantages described herein are not necessarily the only advantages of the invention and it is not necessarily expected that every embodiment of the invention will achieve all of the advantages described.
This invention claims the benefit of priority of U.S. Provisional Application Ser. No. 61/470,196, entitled “Stent Designs Having Enhanced Radiopacity,” filed Mar. 31, 2011, the disclosure of which is hereby incorporated by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
61470196 | Mar 2011 | US |